IDH1 and glioblastoma: Moreover, the different G500 allele frequency, the absence of IDH1 mutations, and the different effect of mutant TP53 on survival (also replicated in this GBM cohort, data not shown) on survival mitigates against these “None” GBMs being miss-classified as telomerase or ALT tumors [7].